← Open Payments lookup

SUSAN GILL: Open Payments

NPI 1225280464 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,459 in 194 payments from 27 companies in 2025. Trend: 2023 $4,321 · 2024 $3,142 · 2025 $4,459

Food & beverage: $4,294Education: $164
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP30$720
Regeneron Healthcare Solutions, Inc.17$557
GlaxoSmithKline, LLC.26$461
GENZYME CORPORATION9$310
Takeda Pharmaceuticals U.S.A., Inc.14$282
Insmed, Inc.16$231
Boehringer Ingelheim Pharmaceuticals, Inc.7$195
Verona Pharma, Inc.8$188
Actelion Pharmaceuticals US, Inc.13$170
Lilly USA, LLC3$149

Products named: DUPIXENT, NUCALA, AIRSUPRA, Arikayce, FASENRA, CUVITRU, Ohtuvayre, TRELEGY ELLIPTA.

Industry payments across FL — which companies pay providers there.